Alterity Therapeutics (ATHE) Other Accumulated Expenses (2019 - 2025)

Alterity Therapeutics' Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $89.29 for Q4 2025.

• In Q4 2025, Other Accumulated Expenses fell 7.11% year-over-year to $89.29; the TTM figure through Dec 2025 stood at $89.29 (down 7.11% YoY), while the FY2025 annual figure was $89.02, down 91.1% from the prior year.
• Other Accumulated Expenses was $89.29 for Q4 2025 at Alterity Therapeutics, roughly flat from $89.02 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $116587.2 in Q4 2023 to a low of $89.02 in Q2 2025.
• Historically, Other Accumulated Expenses has averaged $46163.6 across 5 years, with a median of $40478.1 in 2022.
• The sharpest annual moves came in 2021 and 2024: Other Accumulated Expenses surged 434.74% in 2021, then plunged 99.92% in 2024.
• A 5-year view of Other Accumulated Expenses shows it stood at $11049.2 in 2021, then soared by 259.09% to $39676.2 in 2022, then soared by 193.85% to $116587.2 in 2023, then slumped by 99.92% to $96.13 in 2024, then slipped by 7.11% to $89.29 in 2025.
• The last three Other Accumulated Expenses figures came in at $89.29 (Q4 2025), $89.02 (Q2 2025), and $96.13 (Q4 2024), per Business Quant data.